⌘K

Home/Filings/4/0001626533-20-000027

4//SEC Filing

ARNETT JEAN M 4

Accession 0001626533-20-000027

CIK 0001493712other

View on SEC.gov Company Profile

Filed

Aug 31, 8:00 PM ET

Accepted

Sep 1, 6:16 PM ET

Size

6.6 KB

Accession

0001626533-20-000027

Insider Transaction Report

Form 4

Period: 2020-08-13

Cell MedX Corp.CMXC

DirectorVP, Corporate Strategy10% Owner

Transactions

Exercise/Conversion
Stock Options (Right to Buy)
2020-08-13+1,250,000→ 0 total
Exercise: $0.05From: 2015-08-20Exp: 2020-08-20→ Common Stock (1,250,000 underlying)
Exercise/Conversion
Common Shares
2020-08-13$0.05/sh+1,250,000$62,500→ 6,250,000 total

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Cell MedX Corp.

CIK 0001493712

Entity typeother

Related Parties

1

filerCIK 0001626660

Filing Metadata

Form type: 4
Filed: Aug 31, 8:00 PM ET
Accepted: Sep 1, 6:16 PM ET
Size: 6.6 KB

View on SEC.gov